Hosted on MSN4mon
Knockout of CD5 on CAR T cells shown to boost anti-tumor efficacy
The effectiveness of CAR T cell therapy against a variety of cancers, including solid tumors, could be boosted greatly by using CRISPR-Cas9 technology to knock out the gene for CD5, a protein ...
Business Insider20d
Vittoria Biotherapeutics Completes $25 Million in Private Financing to Propel Groundbreaking Cell Therapy Candidates
VIPER-101 leverages the company’s proprietary Senza5 TM platform technology, which enhances T cell effector function by abrogating CD5-mediated immunosuppression through gene editing.
MyChesCo on MSN3d
Vittoria Biotherapeutics Showcases Advancements in T Cell Therapies at 66th ASH Annual Meeting
PHILADELPHIA, PA — Vittoria Biotherapeutics will present groundbreaking research on its innovative Senza5™ platform at the 66th American Society of Hematology (ASH) Annual Meeting in San Diego, CA, ...
Vittoria Biotherapeutics Announces Oral and Poster Presentations at the 66th American Society of Hematology (ASH) Annual Meeting
Vittoria Biotherapeutics, a clinical-stage immunotherapy company specializing in the development of innovative cell therapies ...
What Hi-Fi?18d
Arcam CD5 review
At £699 / $699, the new Arcam CD5 could be hitting a sweet spot in a price range that has long gathered dust, just like many an audiophile’s CD collection. And if its amplifier siblings’ performances ...
Taiwan News20d
Vittoria Biotherapeutics Completes $25 Million in Private Financing to Propel Groundbreaking Cell Therapy Candidates
Vittoria Biotherapeutics, Inc ., a clinical-stage immunotherapy company specializing in the development of innovative cell therapies for hard-to-treat diseases, today announced the successful ...